---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-332152"
form_type: "8-K"
ticker: "CLSDQ"
cik: "0001539029"
company_name: "Clearside Biomedical, Inc."
filed_at: "2025-12-29T23:59:59+00:00"
generated_at: "2026-05-16T12:06:12.900523+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Clearside Biomedical bankruptcy court approves sale process; Health Ocean Limited as stalking horse

## Summary
- Court approved bidding procedures on Dec 19, 2025; Health Ocean Limited designated as stalking horse bidder.
- Monthly operating report: $3.05M cash; net loss of $490,885 for seven days ending Nov 30, 2025.
- Total assets negative $24.4M, equity negative $26.9M; prepetition unsecured debt $2.3M.
- No employee payroll; no professional fees paid during period; court authorized tax payments.
- Sale process subject to higher or better offers; auction to follow bidding procedures.

## SEC filing metadata
- accession: 0001193125-25-332152
- form_type: 8-K
- ticker: CLSDQ
- cik: 0001539029
- company_name: Clearside Biomedical, Inc.
- filed_at: 2025-12-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.95
- confidence: high
- sec_items: 1.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1539029/000119312525332152/0001193125-25-332152-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1539029/000119312525332152/d63805d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-332152
- JSON: https://secwatch.observer/filing/0001193125-25-332152.json
- Plain text: https://secwatch.observer/filing/0001193125-25-332152.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.